Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × belinostat × 1 year × Clear all

Sponsor

Conditions

Lymphoma, T-Cell, Peripheral 3 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 Uveal Melanoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Mycosis Fungoides 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Eye Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1 Blast Crisis 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡